FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

2945411000001101: Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25921101000001114 Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25921201000001119 Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38120801000001117 Beconase Hayfever 50micrograms/dose nasal spray (GlaxoSmithKline Consumer Healthcare) 180 dose en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
72645201000001113 Beconase Hayfever 50micrograms/dose nasal spray (Omega Pharma Ltd) 180 dose en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Is a Beclometasone 50micrograms/actuation nasal spray 180 dose true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Is pack of Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) false Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Has active ingredient Beclometasone dipropionate false Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Has excipient Benzalkonium chloride false Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Has manufactured dose form Spray dose form false Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Has AMP Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Has specific active ingredient Beclometasone dipropionate true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Beconase Hayfever 50micrograms/actuation nasal spray (GlaxoSmithKline) 180 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start